Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Artigo em Inglês | MEDLINE | ID: mdl-24021773

RESUMO

OBJECTIVE: The maximum surgical blood ordering schedule (MSBOS) has reduced but not eliminated the over-ordering and wastage of blood products. Electronic cross-matching (ECM) may be a suitable alternative method to provide blood on demand in eligible cases. The purpose of this study was to assess the department's current blood ordering policy and to identify patients eligible for ECM. STUDY DESIGN: This was a retrospective observational study of 88 consecutive maxillofacial surgical oncology patients. RESULTS: A total of 383 units of blood were cross-matched, of which 43% were not transfused. Of these, 38% were reallocated and 5% discarded. Of all cross-matched blood, 82% was eligible for ECM; 18% was not eligible, 6% because of the presence of antibodies and 12% because of lack of a second historical sample. CONCLUSIONS: ECM is recommended as a safe method for elective surgery. Blood can be provided on demand, reducing workload and costs for transfusion services and minimizing wastage.


Assuntos
Tipagem e Reações Cruzadas Sanguíneas/métodos , Transfusão de Sangue/estatística & dados numéricos , Neoplasias de Cabeça e Pescoço/cirurgia , Perda Sanguínea Cirúrgica , Feminino , Humanos , Masculino , Período Pré-Operatório , Estudos Retrospectivos , País de Gales
2.
Ann Surg Oncol ; 19(11): 3528-33, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22411202

RESUMO

BACKGROUND: Sentinel lymph node biopsy (SLNB) is an established technique in breast and melanoma surgery and is gaining acceptance in the management of oral cavity squamous cell carcinoma. We report a single institution's experience of SLNB between 2006 and 2010. METHODS: Prospective consecutive cohort study of 59 patients recruited between 2006 and 2010. All patients underwent SLNB with preoperative lymphoscintigraphy, intraoperative blue dye, and handheld gamma probe. Sentinel nodes were evaluated with step-serial sectioning and immunohistochemistry. Endpoints included: overall survival (OS), disease-specific survival (DSS), local recurrence-free survival (LRFS), and regional recurrence-free survival (RRFS). RESULTS: A total of 59 patients (36 male and 23 female) were operated on. Of these, 42 patients (71%) were pT1 and 17 patients (29%) were pT2. In two patients the sentinel node was not identified and proceeded to elective neck dissection. A total of 150 nodes were harvested from the remaining 57 patients of which 21 nodes were positive in 17 patients; three patients had positive contralateral nodes. The 2-year OS, DSS, LRFS, and RRFS for the SLNB negative patients were 97.5, 100, 95.8, and 95.8% and for the SLNB positive patients 68.2, 81.8, 83.9, and 100% respectively. Only OS and DSS approached statistical significance with P values of 0.07 and 0.06. CONCLUSIONS: SLNB is a safe and accurate diagnostic technique for staging the neck with a negative predictive value in our series of 97.5%. Furthermore, in our series three patients (5%) had positive contralateral neck drainage that would have been missed by conventional ipsilateral neck dissection.


Assuntos
Carcinoma de Células Escamosas/secundário , Linfonodos/patologia , Linfonodos/cirurgia , Neoplasias Bucais/patologia , Recidiva Local de Neoplasia/patologia , Biópsia de Linfonodo Sentinela , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma de Células Escamosas/radioterapia , Carcinoma de Células Escamosas/cirurgia , Intervalo Livre de Doença , Feminino , Humanos , Estimativa de Kaplan-Meier , Metástase Linfática , Masculino , Pessoa de Meia-Idade , Neoplasias Bucais/radioterapia , Neoplasias Bucais/cirurgia , Esvaziamento Cervical , Estadiamento de Neoplasias , Valor Preditivo dos Testes , Radioterapia Adjuvante
3.
Eur Arch Otorhinolaryngol ; 266(2): 261-5, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19057923

RESUMO

Multidisciplinary meetings (MDMs) are an essential part of the management of head and neck cancer. Practice care guidance set up by the British Association of Head and Neck Oncologists has recommended that MDMs should have appropriate projection equipment for computer-generated images so that all members of group have access to the same information. The aim of this paper is to review our experience with the integrated visual presentation of head and neck oncology patients and to demonstrate its advantages over conventional approaches. Digital photographs are taken of patients and of their index tumour at presentation or at the time of diagnostic endoscopy. All relevant pre-treatment digitised images from tumour sites and radiological images and histological slides are incorporated into a single presentation using Microsoft PowerPoint software. During the past 2 years, on-line radiological scans have also become accessible for the meeting to aid treatment planning. Subsequently, all peri-operative pictures and post-surgical macroscopic and microscopic histopathological images are added to each patient's presentation, which is then hyperlinked into the agenda. The Guy's and St Thomas' Head and Neck Cancer Centre treats over 400 patients a year, and since 2002, all new cancer diagnoses have been discussed in the weekly MDM as described above. A total of 1,638 presentations have been incorporated in a centralized database that is updated in the event of recurrence, further primary tumours or other clinical developments. Satisfactory documentation and staging of head and neck tumours must include a verbal description, accurate measurement, diagrammatic representation, photographic recording and appropriate radiological imaging. Integrated presentation at MDM collates all relevant findings for clinical management decisions on patients with head and neck cancer. This approach is also an extremely valuable adjunct to long-term clinical monitoring.


Assuntos
Meios de Comunicação , Neoplasias de Cabeça e Pescoço/diagnóstico , Neoplasias de Cabeça e Pescoço/terapia , Equipe de Assistência ao Paciente , Centros Médicos Acadêmicos , Biópsia por Agulha , Institutos de Câncer , Administração de Caso , Quimioterapia Adjuvante , Terapia Combinada , Prestação Integrada de Cuidados de Saúde/métodos , Diagnóstico por Imagem/métodos , Feminino , Humanos , Comunicação Interdisciplinar , Masculino , Estadiamento de Neoplasias , Radioterapia Adjuvante , Sensibilidade e Especificidade , Reino Unido
4.
J Gen Virol ; 89(Pt 7): 1553-1562, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18559924

RESUMO

Human metapneumovirus (HMPV) causes acute respiratory tract illness primarily in young children, immunocompromised individuals and the elderly. Vaccines would be desirable to prevent severe illnesses in these risk groups. Here, we describe the generation and evaluation of cold-passage (cp) temperature-sensitive (ts) HMPV strains as vaccine candidates. Repeated passage of HMPV at low temperatures in Vero cells resulted in the accumulation of mutations in the viral genome. Introduction of these mutations in a recombinant HMPV by reverse genetics resulted in a ts-phenotype, judged on the decreased shut-off temperature for virus replication in vitro. As an alternative approach, three previously described cp-respiratory syncytial virus (cp-HRSV) mutations were introduced in a recombinant HMPV, which also resulted in a low shut-off temperature in vitro. Replication of these ts-viruses containing either the cp-HMPV or cp-HRSV mutations was reduced in the upper respiratory tract (URT) and undetectable in the lower respiratory tract (LRT) of hamsters. Nevertheless, high titres of HMPV-specific antibodies were induced by both ts-viruses. Upon immunization with the ts-viruses, the LRT of hamsters were completely protected against challenge infection with a heterologous HMPV strain, and URT viral titres were reduced by 10 000-fold. In conclusion, we provide proof-of-principle for two candidate live-attenuated HMPV vaccines that induce cross-protective immunity to prevent infection of the LRT in Syrian golden hamsters. Further mapping of the molecular determinants of attenuation of HMPV should be the subject of future studies.


Assuntos
Temperatura Alta , Metapneumovirus/crescimento & desenvolvimento , Metapneumovirus/imunologia , Infecções por Paramyxoviridae/imunologia , Infecções por Paramyxoviridae/prevenção & controle , Vacinas Virais/imunologia , Animais , Anticorpos Antivirais/sangue , Chlorocebus aethiops , Cricetinae , Feminino , Pulmão/virologia , Metapneumovirus/genética , Mutação , Pneumonia Viral/prevenção & controle , Vírus Sinciciais Respiratórios/genética , Sistema Respiratório/virologia , Infecções Respiratórias/prevenção & controle , Infecções Respiratórias/virologia , Células Vero , Vacinas Virais/genética , Replicação Viral/efeitos da radiação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...